Skip to the questions
Care, in question

Questions before care

The medicine and the reason matter

Will my plan pay for this exact use?

Take the exact product name and the treatment goal to the plan. Ask for a clear answer before counting on help with the bill.

Coverage is not a single yes or no

Ask about

What the answer needs to cover

Workplace or private cover

Ask whether this product and this use are on your plan’s list, and whether approval is needed before it pays.

Medicare’s drug benefit

Medicare’s drug benefit is called Part D.

Basic Part D did not cover drugs solely for losing weight under the September 2026 rules.

Part D could help pay when the medicine treated another accepted medical problem, such as type 2 diabetes or reducing heart attack and stroke risk. The exact medicine and use still had to meet the plan’s rules in September 2026.

A separate temporary program

At the September 2026 check, the Medicare GLP-1 Bridge offered a $50 monthly charge to eligible people.

The program’s scheduled start was July 1, 2026, with an end planned for December 31, 2027.

A plan or program may help pay for a medicine, but it still has to check whether it will pay for you.

The Bridge has its own limits

September 2026 rules sent people with type 2 diabetes to ordinary Part D care instead of the Bridge.

Other Bridge rules depend on age, weight when treatment began, certain health problems and your kind of Medicare plan. Not everyone with Medicare qualifies.

The September 2026 rules required age 18 or older and used BMI, a number comparing weight with height, from when treatment began.

The weight threshold was BMI 35 or higher, or BMI 30 or higher alongside certain problems involving the heart, kidneys or blood pressure. For BMI 27 or higher, pre-diabetes was one route to qualifying. Another was artery disease producing limb symptoms. A previous stroke could qualify too, as could a past heart attack.

For the BMI 30 group, the listed conditions were heart failure with preserved pumping strength, or kidney disease reaching stage 3a or worse. The blood pressure condition was a top number above 140 or bottom number above 90 despite taking two blood pressure medicines.

A Medicare Advantage plan offering coordinated care and drug cover was one allowed option. A separate Part D plan was the other. A GLP-1 drug payment made by someone’s Part D plan during 2026 ruled that person out of the Bridge for that year.

Other exclusions included moderate to severe sleep apnea, which means breathing repeatedly stops during sleep. The exclusions also covered MASH, a specific fatty liver illness, when scarring was moderate to advanced and cirrhosis was absent. Cirrhosis means the most severe scarring.

The September 2026 terms required a prescription and approval in advance.

The September 2026 Bridge covered semaglutide (Wegovy), tirzepatide (Zepbound KwikPen) and orforglipron (Foundayo).

KwikPen is a device used to give shots of Zepbound. It holds medicine for more than one shot.

Other Zepbound shot devices and small medicine bottles were outside the program in September 2026.

Liraglutide (Saxenda) was absent from the Bridge product list in September 2026.

Ask the prescriber to match these named conditions to your records and check the full Bridge rules with your plan before you count on help.

Check what each payment counts toward

In September 2026, the annual limit for your own Part D drug costs did not include the $50 paid to the Bridge. The deductible also excluded that payment. This is the amount you pay before Part D begins to help.

Under the September 2026 terms, maker savings cards were unavailable to people covered by Medicare, Medicaid or the military.

A savings card lowers the amount you pay with private insurance. A cash offer gives a price when you pay without using insurance. Some maker cash offers allowed Medicare patients in September 2026.

Ask your plan whether your payment counts toward the amount you must pay before it helps or the yearly limit on your own drug costs.

Before counting on cover

  • Who submits the request and who follows up?
  • What would I owe while a decision is pending?
  • What is the plan if payment is refused?